Takeda announces Access to Medicines strategy: 5 notes

The Japanese pharmaceutical company Takeda Pharmaceutical announced its new Access to Medicines strategy, which aims to increase patient access to the company's gastroenterology and oncology medications.

Here's what you need to know:

1. The Access to Medications strategy addresses various barriers patients around the world face while seeking accessible and affordable healthcare.

2. The strategy includes accelerated registration of the company's medicines, increased participation of local centers in clinical trials and establishment of early access programs.

3. The strategy focuses on countries with limited healthcare systems and unmet patient needs, in regions like Africa, Latin America and Southeast Asia.

4. Takeda Pharmaceutical is also opening a new office in Nairobi, Kenya. The company says it will use this office to establish partnerships across Sub-Saharan Africa.

5. At present, the company has established two corporate social responsibility programs: Takeda Initiative and HERhealth. Takeda Initiative supports healthcare workers in Africa through a partnership with the Global Fund and HERhealth addresses the need for women's healthcare services through a partnership with Business for Social Responsibility.

More articles on gastroenterology and endoscopy:
Vitality Biopharma announces new patent filing for IBD pain relief: 4 notes
Elderly patients who undergo IBD surgery show high mortality, complication rates: 4 insights
SpectraScience announces accurate colorectal cancer diagnosis with WavSTAT4: 4 notes

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months